Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.

Kinga Gawlik, Ulrike Mayer, Kristina Blomberg, Arnoud Sonnenberg, Peter Ekblom, Madeleine Durbeej-Hjalt

Research output: Contribution to journalArticlepeer-review

44 Citations (SciVal)

Abstract

Transgenically introduced laminin (LN) α1 chain prevents muscular dystrophy in LNα2 chain deficient mice. We now report increased integrin α7Bβ1D synthesis in dystrophic LNα2 chain deficient muscle. Yet, immunofluorescence demonstrated a reduced expression of integrin α7B subunit at the sarcolemma. Transgenic expression of LNα1 chain reconstituted integrin α7B at the sarcolemma. Expression of α- and β-dystroglycan is enhanced in LNα2 chain deficient muscle and normalized by transgenic expression of LNα1 chain. We suggest that LNα1 chain in part ameliorates the development of LNα2 chain deficient muscular dystrophy by retaining the binding sites for integrin α7Bβ1D and α-dystroglycan, respectively.
Original languageEnglish
Pages (from-to)1759-1765
JournalFEBS Letters
Volume580
Issue number7
DOIs
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Biological Sciences

Keywords

  • Integrin
  • Dystroglycan
  • Laminin
  • Muscular dystrophy

Fingerprint

Dive into the research topics of 'Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.'. Together they form a unique fingerprint.

Cite this